The review discusses fifty eight peptides in different clinical phases, indicating a strong pipeline of peptide therapies concentrating on PPIs.Clinical trials and preclinical studies are highlighted, displaying the efficacy of peptide vaccines in inducing an immune response, with the opportunity to boost survival prices for HCC individuals.Delve i